Magnetic nanobubbles with potential for targeted drug delivery and trimodal imaging in breast cancer: an in vitro study

Nanomedicine (Lond). 2017 May;12(9):991-1009. doi: 10.2217/nnm-2017-0027. Epub 2017 Mar 13.

Abstract

Aim: The aim of this study was to improve tumor-targeted therapy for breast cancer by designing magnetic nanobubbles with the potential for targeted drug delivery and multimodal imaging.

Materials & methods: Herceptin-decorated and ultrasmall superparamagnetic iron oxide (USPIO)/paclitaxel (PTX)-embedded nanobubbles (PTX-USPIO-HER-NBs) were manufactured by combining a modified double-emulsion evaporation process with carbodiimide technique. PTX-USPIO-HER-NBs were examined for characterization, specific cell-targeting ability and multimodal imaging.

Results: PTX-USPIO-HER-NBs exhibited excellent entrapment efficiency of Herceptin/PTX/USPIO and showed greater cytotoxic effects than other delivery platforms. Low-frequency ultrasound triggered accelerated PTX release. Moreover, the magnetic nanobubbles were able to enhance ultrasound, magnetic resonance and photoacoustics trimodal imaging.

Conclusion: These results suggest that PTX-USPIO-HER-NBs have potential as a multimodal contrast agent and as a system for ultrasound-triggered drug release in breast cancer.

Keywords: PEGlyated PLGA; magnetic resonance; nanobubble; photoacoustic; target; ultrasound.

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / pharmacology
  • Breast / diagnostic imaging
  • Breast / drug effects
  • Breast Neoplasms / diagnostic imaging*
  • Breast Neoplasms / drug therapy*
  • Cell Line, Tumor
  • Contrast Media / chemistry
  • Dextrans / chemistry*
  • Drug Delivery Systems / methods*
  • Female
  • Humans
  • Magnetic Resonance Imaging / methods
  • Magnetite Nanoparticles / chemistry*
  • Microbubbles*
  • Multimodal Imaging / methods
  • Paclitaxel / administration & dosage*
  • Paclitaxel / pharmacology
  • Photoacoustic Techniques / methods
  • Trastuzumab / administration & dosage*
  • Trastuzumab / pharmacology
  • Ultrasonography / methods

Substances

  • Antineoplastic Agents
  • Contrast Media
  • Dextrans
  • Magnetite Nanoparticles
  • ferumoxtran-10
  • Trastuzumab
  • Paclitaxel